NET PROFIT (x1000 DKK)
EMPLOYEES
Ascelia Pharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
2,650
|
1,464
|
13,429 |
Earnings before taxes |
-88,979
|
-94,180
|
-73,929 |
EBITDA |
-97,536
|
-99,557 | |
Total assets |
146,055
|
242,493
|
189,273 |
Current assets |
107,498
|
199,678
|
145,508 |
Current liabilities |
25,070
|
18,255
|
13,609 |
Equity capital |
120,856
|
223,836
|
174,955 |
- share capital |
23,302
|
25,141
|
17,409 |
Employees (average) |
22
|
20
|
11 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
82.7%
|
92.3%
|
92.4% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-59.1%
|
-38.2%
|
-32.0% |
Current ratio |
428.8%
|
1093.8%
|
1069.2% |
Return on equity (ROE) |
-73.6%
|
-42.1%
|
-42.3% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
2
|
9
|
4 |
Chg. No. of employees % |
10%
|
82%
|
57% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.